Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance.
about
Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen.Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding.Trends in nosocomial bloodstream infections in a burn intensive care unit: an eight-year survey.Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistanceStaphylococcus aureus bacteremias following liver transplantation: a clinical analysis of 20 casesCommunity-associated methicillin-resistant Staphylococcus aureus: a review.Nursing home-acquired bloodstream infection.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay, 2002-2004.The Prevalence of MRSA Nasal Carriage in Preoperative Pediatric Orthopaedic PatientsImpact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposureMolecular epidemiology of hospital-onset methicillin-resistant Staphylococcus aureus infections in Southern Chile.Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.Predictors of methicillin resistance in healthcare-associated Staphylococcus aureus bloodstream infections: the role of recent antibiotic use.Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit.Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates.Optimizing delivery of care for patients with MRSA infection: focus on transitions of care.Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients.Methicillin-resistant Staphylococcus aureus bloodstream infection: risk factors and clinical outcome in non-intensive-care units.
P2860
Q33785642-2118DE31-4207-468B-811B-E5C5A3358E80Q33836490-8504F850-F764-472C-9F63-6656F5467124Q34110801-4D72D06A-B279-4484-88E7-C1D713B97B4DQ34718540-AABD5A7D-5E92-47FA-B3F1-2030EDCF4260Q35191519-146305AE-5FDC-41BB-97ED-DE05DC9819E4Q35280740-CF036C11-01E5-415D-AEB3-EC6558656E7DQ35635895-35BE8646-1CE6-44FF-BEDE-8FD32C14DA74Q35754901-982D5E5D-4593-41CC-9956-B2A52BDB24FBQ36070903-9221FA42-23E5-471E-871C-1F08F8D6033BQ36309126-A2F7301E-8C6F-4FF4-918A-E84833A8E733Q36409465-BF396DDF-FF0C-4F2B-A30D-EA01CB2E0BCAQ36861645-53AA95D3-3E39-4510-A93D-2C3AB52E1B6FQ37009576-0691BB65-2875-4295-BBA4-561E4072330EQ37263805-8413F1B6-A281-45D4-9199-3E43D32377FCQ37625071-0A170A04-8990-4C41-9ED6-842F732992FEQ41825567-65061D01-6F09-487A-97C9-05B2F8D98601Q42259050-E840DB59-9851-46FF-8B8D-30C62F642B13Q42686505-CC14C723-C4BA-47F9-BD3D-C8DD785B0061Q42751894-307AC2FE-A047-4EDA-8477-CDB69677CD66Q43195358-1C9DC056-348A-4AB1-A770-BCDBC1A837E5Q43620147-93807D78-32CB-40AD-9F11-331662695491Q45183500-D6AF1908-4E55-44C3-B7AE-004073A6EEFDQ45999362-BB5AACE2-D0CA-4060-8F6B-B789ABD23981Q50949205-9186BFF5-7C84-4661-B3D1-3D2FCB0B7036
P2860
Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prediction model to identify p ...... sk for methicillin resistance.
@en
type
label
Prediction model to identify p ...... sk for methicillin resistance.
@en
prefLabel
Prediction model to identify p ...... sk for methicillin resistance.
@en
P2093
P2860
P356
P1476
Prediction model to identify p ...... sk for methicillin resistance.
@en
P2093
Michael Rybak
Peggy S McKinnon
Thomas P Lodise
P2860
P304
P356
10.1086/502269
P577
2003-09-01T00:00:00Z